Mkts

Collegium Pharmaceutical, Inc.

NASDAQ: COLL
$24.21-0.95 (-3.78%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
23.7124.80
52-week range
21.4350.79
Today
Open24.06
Previous close24.21
Volume401.9K
Valuation
Market cap788.17M
P/E ratio16.45×
EPS (TTM)1.11
Income & risk
Dividend / yield—
Beta0.71
Avg volume714.2K
Discussion

COLL News

Stories mentioning COLL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue193,520205,449209,361188,000177,757181,949159,301145,276
Cost of Goods Sold76,27477,07180,19079,61680,43383,66162,50754,470
Gross Profit117,246128,378129,171108,38497,32498,28896,79490,806
Operating Expenses
Research & Development
Sales General & Admin86,35067,64067,10373,63776,42363,09161,95543,335
Total Operating Expenses86,35067,62167,08473,27975,63760,17761,95543,335
Operating Income (Loss)30,89660,75762,08735,10521,68738,11134,83947,471
Interest Income3,1162,3832,2253,2804,397
Interest Expense
Other Expense
Pretax Income18,74029,03643,43617,0253,12217,26915,58029,097
Tax Provision4,24412,07311,9295,042705.004,7336,2459,491
Net Income (Loss)14,49616,96331,50711,9832,41712,5369,33519,606
Earnings Per Share (Basic)0.450.541.000.380.080.390.290.60
Earnings Per Share (Diluted)0.400.460.840.340.070.360.270.52
Weighted Average Shares Outstanding (Basic)32,08731,65331,57131,81131,79432,07932,25932,433
Weighted Average Shares Outstanding (Diluted)40,06640,07639,44039,07632,84040,11040,16340,384

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About COLL

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is a stock listed on the Nasdaq Stock Market under the ticker symbol COLL. It last traded at $24.21 (Nov 6, 2026, 4:00 PM ET), down 3.8% on the day. That gives Collegium Pharmaceutical a market capitalisation of $788.2M and a price-to-earnings ratio of 16.4.

Over the past 52 weeks COLL has traded between $21.43 and $50.79.

Revenue for the quarter ended Mar 31, 2026 was $193.5M; net income $14.5M. Revenue was up 8.9% from $177.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$193.5M$14.5M7.5%
Dec 31, 2025$205.4M$17.0M8.3%
Sep 30, 2025$209.4M$31.5M15.0%
Jun 30, 2025$188.0M$12.0M6.4%

From Collegium Pharmaceutical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…